[Adrenal cortex insufficiency after combination therapy with itraconazole and budesonide].
Skov
Marianne
M
H:S Rigshospitalet, Juliane Marie Centret, CF Centret og Afdelingen for Vaekst og Reproduktion, og Abdominalcentret, Hepatologisk Afdeling, København Ø. mskov@dadlnet.dk
Main
Katharina Maria
KM
Sillesen
Ida Blok
IB
Müller
Jørn R
JR
Koch
Christian
C
Thorsteinsson
Susanne Lanng
SL
D000293:Adolescent; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000378:metabolism; D000935:Antifungal Agents / Q000009:adverse effects* / Q000378:metabolism; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000378:metabolism; D019819:Budesonide / Q000009:adverse effects* / Q000378:metabolism; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects* / Q000378:metabolism; D008297:Male; D010913:Pituitary-Adrenal System / Q000187:drug effects*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D001993:Bronchodilator Agents; D017964:Itraconazole; D019819:Budesonide; D000324:Adrenocorticotropic Hormone